Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Non-Current Assets (2020 - 2025)

Definitive Healthcare's Non-Current Assets history spans 6 years, with the latest figure at $12.7 million for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 234.48% year-over-year to $12.7 million; the TTM value through Dec 2025 reached $12.7 million, up 234.48%, while the annual FY2025 figure was $12.7 million, 234.48% up from the prior year.
  • Non-Current Assets reached $12.7 million in Q4 2025 per DH's latest filing, down from $509.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.7 billion in Q1 2023 to a low of $3.8 million in Q4 2024.
  • Average Non-Current Assets over 5 years is $512.7 million, with a median of $12.7 million recorded in 2025.
  • Peak YoY movement for Non-Current Assets: soared 35274.39% in 2023, then tumbled 62.61% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $5.1 million in 2021, then decreased by 11.94% to $4.5 million in 2022, then grew by 0.16% to $4.5 million in 2023, then fell by 15.21% to $3.8 million in 2024, then skyrocketed by 234.48% to $12.7 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Non-Current Assets are $12.7 million (Q4 2025), $509.2 million (Q3 2025), and $521.0 million (Q2 2025).